RA

Atlantic City, New Jersey, U.S., September 28, 2026 SetPoint Medical has announced an important clinical-access milestone following the completion...

SAN DIEGO, California — September 8, 2026 Artiva Biotherapeutics, Inc. announced planned clinical data disclosures and development milestones for...

Lund, Sweden, September 7, 2026 SynAct Pharma AB has reported further analyses from its Phase 2b ADVANCE clinical trial...

WALTHAM, Mass. — August 25, 2026 Spyre Therapeutics, Inc. announced topline results from the rheumatoid arthritis (RA) sub-study of...

TEL AVIV, Israel, and BURLINGTON, Mass., July 8, 2026 Chemomab Therapeutics and Scipher Medicine have entered into a definitive...

ROCKVILLE, Maryland, June 2, 2026 Rise Therapeutics announced the completion of full enrollment in the four-week dose expansion cohort...